Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Cigarette smoke may prime lung stem cells for different types of lung cancer (opens in a new tab)

medicalxpress.com · 2026-10-05

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 2 supported
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Two of five claims match the study. This overall rating is based only on the claims we could check. Three claims the study doesn't address.

  • 2 supported
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredUsing laboratory-grown lung organoids over six months of cigarette smoke condensate exposure, researchers found altered epigenetic programming and gene expression in different lung stem cell populations, creating distinct precancerous cell states.View evidenceHide evidence

As statedsix months

Why this verdict

The core scientific content is supported at abstract level: normal lung organoids exposed to chronic cigarette smoke condensate developed distinct premalignant stem-cell states with progressive epigenetic abnormalities linked to transcriptomic changes. However, the specific “six months” exposure duration is not provided in the supplied abstract-depth profile, so the claim as stated cannot be fully verified at this evidence depth.

1

Study evidence

Chronic CSC exposure drives two distinct lung organoid stem cell populations to evolve premalignant states with progressive epigenetic abnormalities that are linked to transcriptomic changes, occurring in the absence of major driver mutations.

“Using normal lung organoids (LOs), we define how chronic cigarette smoke condensate (CSC) exposure drives two separate stem cell populations to evolve premalignant states harboring progressive epigenetic and linked transcriptomic abnormalities in the absence of major driver mutations.”
Claim 2 of 5Not coveredSmoke-exposed organoids containing one of the genetic alterations formed tumors, whereas cigarette smoke exposure alone did not produce tumors and the genetic alterations did not transform unexposed control organoids.View evidenceHide evidence

As statedsix months

Why this verdict

The profile supports that CSC-exposed organoids with introduced KrasG12V or Tp53 loss underwent one-step transformation and that CSC exposure alone generated premalignant states in the absence of major driver mutations. But the specific control assertion that the same genetic alterations did not transform unexposed control organoids is not reported in the supplied abstract-depth profile, so the full claim is not verifiable at this depth.

1

Study evidence

Chronic CSC exposure drives two distinct lung organoid stem cell populations to evolve premalignant states with progressive epigenetic abnormalities that are linked to transcriptomic changes, occurring in the absence of major driver mutations.

“Using normal lung organoids (LOs), we define how chronic cigarette smoke condensate (CSC) exposure drives two separate stem cell populations to evolve premalignant states harboring progressive epigenetic and linked transcriptomic abnormalities in the absence of major driver mutations.”
2

Study evidence

Introduction of KrasG12V into CSC-exposed lung organoids drives tumorigenesis primarily in a bronchioalveolar stem cell-derived state, producing adenocarcinomas.

“The stem cell populations evolve through distinct trajectories to respond differently to subsequent introduction of oncogenic mutations, KrasG12V and loss of Tp53, to induce one step transformation of CSC exposed organoids resulting in two major NSCLC subtypes.”
Claim 3 of 5Not coveredThe paper, reported Oct. 5 in Proceedings of the National Academy of Sciences, suggests that environmental exposure, epigenetic changes and genetic mutations may work together during the earliest stages of non-small cell lung cancer.View evidenceHide evidence

As statedOct. 5

Why this verdict

The scientific interpretation—that environmental exposure, epigenetic/transcriptomic changes, and later genetic drivers may interact in early NSCLC development—is supported by the abstract-level profile and is appropriately hedged. However, the exact publication detail “reported Oct. 5 in Proceedings of the National Academy of Sciences” is not present in the supplied paper profile, so the claim as a whole is not fully verifiable from the provided abstract-depth evidence.

1

Study evidence

Chronic CSC exposure drives two distinct lung organoid stem cell populations to evolve premalignant states with progressive epigenetic abnormalities that are linked to transcriptomic changes, occurring in the absence of major driver mutations.

“Using normal lung organoids (LOs), we define how chronic cigarette smoke condensate (CSC) exposure drives two separate stem cell populations to evolve premalignant states harboring progressive epigenetic and linked transcriptomic abnormalities in the absence of major driver mutations.”
2

Study evidence

Introduction of KrasG12V into CSC-exposed lung organoids drives tumorigenesis primarily in a bronchioalveolar stem cell-derived state, producing adenocarcinomas.

“The stem cell populations evolve through distinct trajectories to respond differently to subsequent introduction of oncogenic mutations, KrasG12V and loss of Tp53, to induce one step transformation of CSC exposed organoids resulting in two major NSCLC subtypes.”
Claim 4 of 5SupportedChronic exposure to cigarette smoke may reprogram different populations of lung stem cells in ways that make them vulnerable to specific cancer-causing gene alterations and help determine the type of lung cancer that develops.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the headline-level idea that chronic cigarette smoke condensate drives distinct lung organoid stem-cell populations into premalignant epigenetic/transcriptomic states and that those states respond differently to later KrasG12V or Tp53-loss perturbations, yielding different NSCLC subtype outputs. The claim is hedged with “may,” and its causal framing is consistent with the experimental organoid manipulation described in the abstract.

1

Study evidence

Chronic CSC exposure drives two distinct lung organoid stem cell populations to evolve premalignant states with progressive epigenetic abnormalities that are linked to transcriptomic changes, occurring in the absence of major driver mutations.

“Using normal lung organoids (LOs), we define how chronic cigarette smoke condensate (CSC) exposure drives two separate stem cell populations to evolve premalignant states harboring progressive epigenetic and linked transcriptomic abnormalities in the absence of major driver mutations.”
2

Study evidence

Introduction of KrasG12V into CSC-exposed lung organoids drives tumorigenesis primarily in a bronchioalveolar stem cell-derived state, producing adenocarcinomas.

“The stem cell populations evolve through distinct trajectories to respond differently to subsequent introduction of oncogenic mutations, KrasG12V and loss of Tp53, to induce one step transformation of CSC exposed organoids resulting in two major NSCLC subtypes.”
Claim 5 of 5SupportedWhen KRAS or TP53 alterations were introduced after smoke exposure, the altered stem cell populations responded differently: KRAS mutations drove lung adenocarcinomas primarily from bronchioalveolar stem cell–derived states, while loss of TP53 produced squamous cell carcinomas derived from basal stem cells.View evidenceHide evidence

Why this verdict

The abstract-level profile directly states that CSC-exposed stem-cell populations respond differently to subsequent KrasG12V versus Tp53-loss introduction, with Kras mutations driving tumorigenesis mainly from a bronchioalveolar stem-cell-derived state producing adenocarcinomas, and TP53 loss driving tumorigenesis from a basal stem-cell-derived state producing squamous cell carcinomas.

1

Study evidence

Introduction of KrasG12V into CSC-exposed lung organoids drives tumorigenesis primarily in a bronchioalveolar stem cell-derived state, producing adenocarcinomas.

“The stem cell populations evolve through distinct trajectories to respond differently to subsequent introduction of oncogenic mutations, KrasG12V and loss of Tp53, to induce one step transformation of CSC exposed organoids resulting in two major NSCLC subtypes.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The paper reports an immune-evasive, death-signal-attenuated program involving downregulation of inflammatory/interferon pathways and epigenetic silencing of Zbp1.

    The story covers epigenetic and gene-expression changes generally, but it does not mention immune evasion, interferon/inflammatory pathway downregulation, PANoptosis, or Zbp1 silencing, which are material mechanistic elements in the abstract-level profile.

    From in vitro

  • Tumors arising after CSC exposure show further potentiation of CSC-associated Zbp1/interferon downregulation, with mutation-specific decreases particularly in Kras-mutant contexts.

    The story discusses driver-specific tumor subtype outcomes but omits this additional tumor molecular profiling result and the Kras-context-specific Zbp1/interferon expression finding.

    From other

  • The evidence is from an in vitro lung organoid model; the abstract-depth profile does not establish in vivo validation or direct relevance to human patients.

    The story notes laboratory-grown organoids, but its listed caveats do not explicitly acknowledge the interpretation-changing limitation that the evidence is in vitro and that human or in vivo relevance is not established in the supplied abstract profile.

    From in vitro; In vitro lung organoid transformation assay with oncogene introduction

  • The abstract-depth profile lacks sample sizes, exposure dose/duration details, statistical results, transformation incidence/latency metrics, and detailed methods for subtype or cell-of-origin classification.

    The story’s caveats mention need for additional validation and note that smoke exposure alone did not produce tumors, but they do not acknowledge these abstract-level evidence gaps. The story also states a six-month duration that is not verifiable from the supplied abstract-depth profile.

    From in vitro; In vitro lung organoid transformation assay with oncogene introduction

2 things the story did carry across
  • Chronic cigarette smoke condensate exposure drives two normal lung organoid stem-cell populations into distinct premalignant states with progressive epigenetic and transcriptomic abnormalities, even without major driver mutations.
  • CSC-induced states show driver-specific transformation responses: KrasG12V is linked to bronchioalveolar stem-cell-derived adenocarcinoma, while Tp53 loss is linked to basal stem-cell-derived squamous cell carcinoma.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

4

Evidence read

study summary

Lead result

in vitro

1Lead resultin vitroChronic cigarette smoke condensate (CSC) exposure drives two normal lung organoid stem cell populations into distinct premalignant/immune-evasive states characterized by progressive epigenetic and transcriptomic abnormalities even without major driver mutations (including interferon/inflammatory pathway downregulation).Expand

In plain English

In normal lung organoids, chronic exposure to cigarette smoke condensate (CSC) drives two distinct stem cell populations to evolve premalignant, immune-evasive states characterized by progressive epigenetic alterations coupled to transcriptomic changes (including downregulation of interferon/inflammatory pathways and epigenetic silencing of Zbp1), occurring in the absence of major driver mutations.

Key findings

  • Chronic CSC exposure drives two distinct lung organoid stem cell populations to evolve premalignant states with progressive epigenetic abnormalities that are linked to transcriptomic changes, occurring in the absence of major driver mutations.
  • CSC‑exposed stem cell states acquire an immune‑evasive phenotype characterized by downregulation of interferon/inflammatory pathways and epigenetic silencing of Zbp1.
“Using normal lung organoids (LOs), we define how chronic cigarette smoke condensate (CSC) exposure drives two separate stem cell populations to evolve premalignant states harboring progressive epigenetic and linked transcriptomic abnormalities in the absence of major driver mutations.”
What this piece can’t prove
  • Summary is based on abstract text; the abstract does not specify experimental sample sizes, exposure duration/dose, assay types, or statistical details.
  • Findings are reported from an in vitro normal lung organoid model; the abstract does not report in vivo validation or direct evidence of relevance to human patients.
2in vitroCSC exposure promotes an immune-evasive, death-signal–attenuated state via epigenetic silencing/downregulation of the PANoptosis regulator Zbp1 (and related interferon signaling).Expand

In plain English

In CSC-exposed lung organoids, chronic cigarette-smoke exposure is reported to produce an immune-evasive state with downregulation of inflammatory and interferon signaling and attenuation of cell death signals, mediated by epigenetic silencing of the PANoptosis regulator Zbp1.

Key findings

  • Chronic CSC exposure leads to an immune-evasive, death-signal–attenuated state via epigenetic silencing of the PANoptosis regulator Zbp1, accompanied by downregulation of inflammatory and interferon signaling.
“These dynamics facilitate evolution of an immune evasive state with downregulation of inflammatory pathways and accompanying death signals mediated by epigenetic silencing of PANoptosis regulator, Zbp1.”
What this piece can’t prove

2 further details could not be confirmed from the summary.

3in vitroThese CSC-induced stem cell states exhibit driver-specific transformation responses: introducing KrasG12V versus Tp53 loss yields distinct NSCLC subtype outputs (adenocarcinoma vs squamous), linked to bronchioalveolar vs basal stem-cell–derived states.In vitro lung organoid transformation assay with oncogene introductionExpand

In plain English

In lung organoids chronically exposed to cigarette smoke condensate (CSC), introduction of distinct oncogenic perturbations yields different, driver-specific transformation outcomes: KrasG12V promotes tumorigenesis from a bronchioalveolar stem cell-derived state producing adenocarcinoma, whereas Tp53 loss promotes tumorigenesis from a basal stem cell-derived state producing squamous cell carcinoma. These outcomes occur after CSC-driven evolution of distinct premalignant stem cell states that carry progressive epigenetic and transcriptomic changes and an immune-evasive program (including downregulation of inflammatory/interferon signaling and epigenetic silencing of Zbp1); Zbp1/interferon downregulation is further decreased in Kras-mutant tumors.

Key findings

  • Introduction of KrasG12V into CSC-exposed lung organoids drives tumorigenesis primarily in a bronchioalveolar stem cell-derived state, producing adenocarcinomas.
  • Loss of Tp53 in CSC-exposed lung organoids drives tumorigenesis primarily in a basal stem cell-derived state, producing squamous cell carcinomas.
“The stem cell populations evolve through distinct trajectories to respond differently to subsequent introduction of oncogenic mutations, KrasG12V and loss of Tp53, to induce one step transformation of CSC exposed organoids resulting in two major NSCLC subtypes.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

4otherMutation-specific tumor contexts further potentiate CSC-associated Zbp1/interferon downregulation (e.g., decreased expression in Kras-mutant contexts), defining subtype-associated expression profiles.Expand

In plain English

The authors report that tumors arising after chronic cigarette smoke condensate (CSC) exposure show further potentiation of CSC-associated downregulation of Zbp1 and interferon signaling, with decreased expression particularly evident in Kras-mutant tumor contexts, defining subtype-associated expression profiles.

Key findings

  • CSC-induced downregulation of Zbp1 and interferon signaling is further potentiated in tumors, with decreased expression particularly in Kras-mutant contexts, defining subtype-associated expression profiles.
“CSC-induced downregulation of Zbp1 and interferon signaling is further potentiated in tumors with mutation-specific changes marked by decreased expression in Kras-mutant contexts.”
What this piece can’t prove
  • The abstract does not provide quantitative measures (fold-change, p-values) or sample sizes for the reported decrease in Zbp1/interferon expression.
  • Unclear whether findings are consistent across independent tumor samples or replicates; extent of inter-tumor heterogeneity is not reported.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Chronic cigarette smoke exposure induces distinct stem cell states driving genetic driver-specific non-small cell lung cancer subtypes.

Proceedings of the National Academy of Sciences of the United States of America · 2026

Deep dive in Tessa (opens in a new tab)Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 40 candidate papers

Selected

Chronic cigarette smoke exposure induces distinct stem cell states driving genetic driver-specific non-small cell lung cancer subtypes.

Proceedings of the National Academy of Sciences of the United States of America · 2026 · PubMed, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)
Candidate

FieldTNN-based machine learning method for Maxwell eigenvalue problems

Journal of Computational Physics · 2026 · Crossref

Source (opens in a new tab)

And 34 more candidates considered.